| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 297.96 KB | Adobe PDF |
Advisor(s)
Abstract(s)
Introduction: Liver steatosis measurement by controlled attenuation parameter (CAP) is a noninvasive method for diagnosing steatosis1.
Plasma caspase-generated cytokeratin-18 fragments (CK-18) have been proposed as a non-invasive alternative for the diagnosis of NAFLD, especially NASH2.
Aims: compare CK-18 serum levels in apparently healthy individuals with and without steatosis.
Description
Keywords
Determinantes Imunológicos em Doenças Crónicas Hepatic Steatosis
